Background Alpha-hydroxy acids (AHAs) are widely used for the treatment of hyperkeratotic skin disorders and photodamaged skin. Objectives To investigate the effect of lactic acid (LA) on the secretion of cytokines by keratinocytes (KCs) of human reconstructed epidermis. Methods Creams containing 1´5%, 3% or 5% LA or vehicle controls were topically applied on to human epidermal equivalents (EEs). After 24 h, EEs were analysed for morphology and for the presence of apoptotic cells. Secretion of vascular endothelial growth factor (VEGF), angiogenin (ANG) and interleukin (IL)-8 was measured in the supernatants by enzyme-linked immunosorbent assay.
Topical use of AHAs has been reported to reduce overall severity of photodamage. 6, 7 Histologically, structural changes of both the epidermis and the dermis have been reported after AHA application. These changes comprise an increased thickness of the viable epidermis, 8±10 increased deposition of hyaluronic acid, 8 reduced basal cell atypia and a more undulating rete pattern. In the dermis, increased production of acid mucopolysaccharides, 9 hyaluronic acid and chondroitin sulphate, 8 as well as an increased density of collagen fibres and less fragmented, irregular elastic fibres, 9 have been reported. There are only a few studies addressing the mechanisms by which AHAs may induce these profound structural changes. 11 As AHAs have recently been shown to prevent the regression of skin vessels due to corticosteroids, 10 we investigated the effects of AHAs on the secretion of the angiogenic cytokines vascular endothelial growth factor (VEGF), interleukin (IL)-8 and angiogenin (ANG) by keratinocytes (KCs).
Materials and methods

Epidermal equivalents
Human epidermal equivalents (EEs) grown in collagencoated cell culture inserts without fibroblasts under serum-free conditions (EpiDerm TM ) were obtained from Mattek Corporation (Ashland, MA, U.S.A.). They represent an in vitro reconstructed model for differentiating human epidermis. Individual EE samples have a diameter of 8 mm. EEs were shipped by the manufacturer at 4 8C. Upon arrival, the cell culture inserts were changed from the shipment support into six-well plates containing 900 mL of prewarmed serum-free growth medium provided by the manufacturer. After 2±3 h, medium was changed to 900 mL Dulbecco's modified Eagle's medium (DMEM, Life Technologies, Vienna, Austria) without growth supplements and cultured overnight, after which the topical formulations were applied (see below). For all experiments EEs were kept at the air±liquid interface at 37 8C in a 5% CO 2 /95% air environment in a humidified incubator.
Composition of the creams
The creams used in this study were obtained from the 
Stimulation experiments
After overnight culture of EEs, medium was replaced with 900 mL of fresh DMEM, and creams containing different concentrations of LA or vehicle were applied in 50-mL aliquots directly on to the stratum corneum with a multipipette (Eppendorf, Hamburg, Germany). After 24 or 48 h, supernatants were collected, centrifuged at 17,600 g and stored at 2 70 8C until further analysis. At the same time the EEs, together with the membranes of the cell culture inserts, were cut out, formalin fixed and paraffin embedded. The morphology of EEs was then evaluated by haematoxylin and eosin (H&E) staining of 4-mm sections. Six independent experiments were performed in triplicate. One experiment was excluded from analysis because of inconclusive triplicate determinations of control samples.
Cytokine immunoassays
Cell culture supernatants were analysed for different cytokines using commercial enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturers' instructions: VEGF (CYTElisa-VEGF, CYTimmune Sciences, College Park, MD, U.S.A.), 
Detection of apoptotic cells
Apoptotic cells were identified on H&E-stained sections by the characteristics of apoptosis, i.e. cell shrinkage with condensed, pyknotic nuclei and eosinophilic cytoplasm. Apoptotic cells were counted by two blinded investigators (M.R., C.M.) and an apoptotic index (AI) was calculated ( number of apoptotic cells per cm section). The morphological data were confirmed by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labelling (TUNEL) with the`in situ cell death detection kit' (Boehringer Mannheim, Vienna, Austria) according to the manufacturer's instructions.
Statistical analysis
To compare the different treatment groups Student's t-tests were calculated using the median values of the ELISA triplicate determinations or the mean of the AI. Results were considered significant at P , 0´05.
Results
Effects of lactic acid treatment on the viability of keratinocytes
In a first set of experiments, samples were histologically analysed 24 and 48 h after application of the respective creams. After 48 h the morphology of EEs cultured in DMEM without creams deteriorated, i.e. EEs comprised only two or three instead of four or five layers of nucleated cells (not shown). Therefore, all further experiments were performed for 24 h only. After 24 h, treatment with LA-containing creams led to morphological changes of EEs in a concentration-dependent manner (Fig. 1b±d) : the stratum corneum appeared swollen and showed a decreased staining intensity and the stratum granulosum disappeared. The number of apoptotic cells increased with increasing LA concentration (Fig. 1a±d, arrows) . The apoptotic cells were preferentially located in the basal KC layers. To confirm that these cells underwent apoptosis, we performed TUNEL staining. As depicted in Figure 2 (a±d), distribution and location of TUNEL-positive, bright yellowishgreen nuclei corresponded to apoptotic cells identified by H&E staining. A significant increase in the AI was observed after treatment with all concentrations of LA when compared with vehicle alone, i.e. 1´4-, 2´0-and 2´4-fold with 1´5%, 3% and 5% LA, respectively (Fig. 3) .
Application of lactic acid has different modulatory effects on vascular endothelial growth factor, angiogenin and interleukin-8 secretion by keratinocytes
The supernatants of five independent experiments performed in triplicate were analysed for levels of VEGF, ANG and IL-8. Without application of creams, secretion of VEGF by EEs cultured in DMEM alone ranged from 87 to 236 pg mL 21 (mean^SD 1575 3) after 24 h (Fig. 4a) . Application of vehicle had no significant (P 0´21) effect on VEGF secretion as compared with DMEM (Fig. 4a , vehicle: mean^SD 225^123 pg mL 21 ). By contrast, treatment with creams containing 1´5% and 3% LA increased spontaneous mean^SD VEGF secretion 2´5^0´6 fold (P 0´02) and 2´8^0´9 fold (P 0´045), respectively (Fig. 4a, ) as compared with vehicle, reaching significance with 5% LA (P 0´01).
The baseline level of IL-8 release by EEs ranged from 151 to 499 pg mL 21 (mean^SD 290^132; Fig. 4c ). Changes in mean^SD IL-8 release after treatment with LA-containing creams strongly varied between experiments, leading to a modest increase that did not reach statistical significance (Fig. 4c, 
Discussion
AHAs have been used for the treatment of various skin disorders, including photodamaged skin. 3, 4 In the present study we hypothesized that some of the effects of AHAs are due to their action on KCs and that changes observed in the dermis after AHA treatment 6±9 might be mediated by KC-derived soluble factors; therefore, we investigated the effect of topical AHA application on the spontaneous secretion of the angiogenic cytokines VEGF, ANG and IL-8 by human in vitro reconstructed epidermis.
AHA application differentially modulated the secretion of these three cytokines. The release of VEGF by EEs was significantly increased after treatment with creams containing 1´5% and 3% but not 5% LA, whereas the release of IL-8 was not significantly altered and that of ANG decreased with increasing concentrations of LA.
AHA application clearly showed a toxic effect on the EEs, in that increasing concentrations of LA led to increased apoptotic cell death of KCs as judged by morphology and TUNEL staining. We can exclude the possibility that this effect was due to pH differences of the culture medium because the vehicle control was adjusted to the same pH as AHA-containing creams. Regarding the influence of the osmolarity of the different creams on cell death, we cannot exclude that the higher osmolarity of the 3% and 5% LAcontaining creams (see Materials and methods) contributed to the induction of cell death. However, vehicle alone (which was hyposomolar as compared with culture medium) neither increased cell death nor induced a deterioration of the epidermal architecture, suggesting that the contribution of variation of osmolarity to cell death is slight. Induction of cell death was strongest at 5% LA, where most of the KCs of the EEs were dead. In vivo, much higher concentrations of AHAs are regularly used to obtain therapeutic effects without obvious damage to the epidermis. 3 Only when applied at concentrations as high as 70%, as used for peeling procedures, are irritating and damaging effects to the skin observed. 12 The difference between in vitro and in vivo treatment is probably due to a combination of factors. Although in vitro differentiated EEs have a fully developed and functional stratum corneum, 13±15 their barrier function is reportedly inferior to the epidermal barrier in vivo. Therefore, the amount of LA that reaches the KCs is probably much higher than in the epidermis in vivo. Moreover, in vivo, toxic substances and metabolic products are removed by the skin microcirculation, a mechanism lacking in the in vitro model. As a result, toxic metabolites might accumulate in EEs after AHA treatment and ultimately account for KC apoptosis. These limits of the model have to be taken into account when extrapolating conclusions from data obtained in vitro to the in vivo situation.
VEGF is expressed by KCs in human epidermis 16, 17 and is produced by KCs in monolayer culture. 18 It is regulated by a variety of factors including hypoxia, 19 cytokines, 20 sensitizing and non-sensitizing irritants, 21 and retinoids. 22 Here we report for the first time the regulation of VEGF production by KCs in epidermal organotypic culture. In this system application of LA-containing creams strongly increased the release of VEGF. This increase was due to de novo protein synthesis rather than to the release of preformed protein by dying cells, because in normal EEs only a small proportion of the VEGF found in the supernatant was detected within lysates of EEs (data not shown). Moreover, no upregulation was found with 5% LA, which gave the strongest induction of apoptotic cell death. We do not know at present whether the observed upregulation of VEGF is caused by autocrine or paracrine mechanisms involving other KC-derived cytokines or by the direct action of LA. The exact pathway leading to the induction of VEGF secretion by KCs in EEs remains to be explored.
With regard to the implications of the finding that VEGF production by KCs is upregulated by AHA treatment, alterations of cutaneous vessels are commonly observed in chronic photodamage, 5 and VEGF has major effects on endothelial cells. 23, 24 It stimulates endothelial cells to proliferate, 25 migrate 26 and express genes involved in angiogenesis, 27 resulting in the formation of new blood vessels. Besides its angiogenic properties, VEGF has recently also been reported to act as a potent survival factor for endothelial cells. 28±30 An increased production of VEGF by AHAs in vivo could, therefore, exert a beneficial effect on the skin microvasculature by both helping to maintain it and by inducing the formation of new vessels. A precedent for such an effect exists: Lavker et al. recently showed that topical AHA treatment can prevent the regression of skin microvessels caused by topical corticosteroid treatment and that it appears to increase skin vascularization. 10 It is very likely that the induction of KC-derived VEGF plays a part in the effect observed by these authors. Both other cytokines studied, i.e. IL-8 and ANG, exhibit angiogenic activity in vivo and mitogenic effects on endothelial cells in vitro.
31±34 In this study they were, like VEGF, constitutively secreted by EEs. ANG is expressed by a variety of cell types, 35, 36 and this is the first demonstration that it is produced by human KCs. The biological relevance of its production by KCs remains to be determined. Whereas the production of IL-8 was not regulated by AHA treatment, the release of ANG continuously decreased with increasing concentrations of LA, coinciding with increasing cell death, which might reflect the inability of EEs to maintain baseline ANG production due to increased apoptosis rather than to active downregulation.
In summary, we have demonstrated that topical application of AHAs can modulate the production of cytokines by KCs. We suggest that the increased release of VEGF by KCs after AHA treatment of photodamaged skin may help to halt the regression of skin vessels and lead to neoangiogenesis, thereby contributing to the therapeutic effects observed with these substances. Whether or not topical AHAs induce the production of other cytokines and/or enzymes by KCs will be an interesting area of research in the future.
